US Patent Issued to Mayo Foundation for Medical Education and Research on April 22 for "Using fatty acid synthase inhibitors to treat fibrosis" (Minnesota Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,036, issued on April 22, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).

"Using fatty acid synthase inhibitors to treat fibrosis" was invented by Edward B. Leof (Rochester, Minn.), Ruth Lupu (Rochester, Minn.), Jeong-Han Kang (Rochester, Minn.) and Mi-Yeon Jung (Rochester, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document relates to materials and methods for treating fibrosis (e.g., pulmonary fibrosis). For example, this document provides methods for using one or more fatty acid synthase (FASN) inhibitors to treat a mammal having fibrosis (e.g., pulmonary fibrosis), and/or a complication associa...